These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 9204917)

  • 1. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
    Glass M; Felder CC
    J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
    Felder CC; Joyce KE; Briley EM; Glass M; Mackie KP; Fahey KJ; Cullinan GJ; Hunden DC; Johnson DW; Chaney MO; Koppel GA; Brownstein M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):291-7. PubMed ID: 9435190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP; Howlett AC
    Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
    Obadiah J; Avidor-Reiss T; Fishburn CS; Carmon S; Bayewitch M; Vogel Z; Fuchs S; Levavi-Sivan B
    Cell Mol Neurobiol; 1999 Oct; 19(5):653-64. PubMed ID: 10384262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?
    Kearn CS; Blake-Palmer K; Daniel E; Mackie K; Glass M
    Mol Pharmacol; 2005 May; 67(5):1697-704. PubMed ID: 15710746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
    Holland M; John Challiss RA; Standen NB; Boyle JP
    Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic m1 receptor-stimulated adenylate cyclase activity in Chinese hamster ovary cells is mediated by Gs alpha and is not a consequence of phosphoinositidase C activation.
    Burford NT; Nahorski SR
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):883-8. PubMed ID: 8645172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
    Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB
    Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.
    Abadji V; Lucas-Lenard JM; Chin C; Kendall DA
    J Neurochem; 1999 May; 72(5):2032-8. PubMed ID: 10217281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
    Hall DA; Strange PG
    Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the D2L dopamine receptor expressed in a cAMP-responsive luciferase reporter cell line.
    George SE; Bungay PJ; Naylor LH
    Biochem Pharmacol; 1998 Jul; 56(1):25-30. PubMed ID: 9698085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
    J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
    Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.